Don't let it get away!
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of teeth-straightening specialist Align Technology Inc. (NASDAQ: ALGN ) surged 26% today after its quarterly results and outlook topped Wall Street expectations.
So what: The stock has soared in 2013 on strong sales of its Invisalign braces, and today's third-quarter results -- earnings of $34.5 million on a revenue surge of 21% -- coupled with upbeat fourth-quarter guidance suggests that the momentum isn't slowing. In fact, Invisalign shipments for the quarter climbed 15% while gross margins increased 250 basis points, giving investors plenty of good vibes over its competitive position going forward.
Now what: Management now sees fourth-quarter EPS of $0.41-$0.43 on revenue of $169.1 million-$173.1 million, well above Wall Street's view at $0.36 and $164.3 million, respectively.
"We continue to deliver solid execution of our long-term strategic plan and expect to continue those key initiatives, which are at the core of our progress," CEO Thomas Prescott said in a conference call. "Our results also reflect stable patient traffic in our customers' offices and their willingness to let us become a more significant part of their practices."
Of course, with the shares soaring to a new 52-week high today and trading at a 35-plus forward P/E, I'd wait for some of the excitement to fade before buying into that bullishness.
More healthy health care picks
Obamacare is rewriting the rules for the health care industry, and in the process of doing so, it's creating massive opportunities for investors to get ridiculously rich. How? By investing in a handful of specific health care stocks. In this free report, our analysts walk you through these opportunities and the companies that are positioned to exploit them. The informational edge contained in it is invaluable, but can only be exploited profitably while the rest of the market remains in the dark. To access this free report instantly, simply click here now.